Tech Center 1600 • Art Units: 1623 1693
This examiner grants 61% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18014705 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | Non-Final OA | The Regents of the University of California |
| 17904907 | COMPOSITION AND METHOD TO PREPARE LONG-ACTING INJECTABLE SUSPENSION CONTAINING MULTIPLE CANCER DRUGS | Non-Final OA | University of Washington |
| 18001655 | THERAPEUTIC TREATMENT USING PROTEIN KINASE C (PKC) INHIBITORS AND CYTOTOXIC AGENTS | Non-Final OA | Cambridge Enterprise Limited |
| 17620612 | METHOD FOR ENRICHING NUCLEIC ACIDS BY SIZE | Non-Final OA | QIAGEN GmbH |
| 18026009 | AUTOPHAGY ACTIVATOR | Non-Final OA | Resonac Corporation |
| 17791851 | NEW IMMUNOSTIMULATORS AND USE THEREOF IN IMMUNOTHERAPY | Non-Final OA | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
| 17912805 | NRTIS, NRTI METABOLITES, AND NRTI ANALOGS FOR MACULAR DEGENERATION AND VIRAL INFECTIONS | Final Rejection | University of Virginia Patent Foundation |
| 18229838 | SIZE SELECTION PURIFICATION USING A THERMOPLASTIC SILICA NANOMATERIAL | Non-Final OA | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. |
| 17784474 | RAPID PRECIPITATION-DRIVEN KILOBASE SIZE SELECTION OF HMW DNA | Final Rejection | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. |
| 17960202 | POLYHYDROXYLATED CYCLOPENTANE DERIVATIVES AND METHODS OF USE | Non-Final OA | Sanegene Bio USA Inc. |
| 18305840 | WATER DISPERSABLE FILM-FORMING COMPOSITION | Non-Final OA | AMOREPACIFIC CORPORATION |
| 18284991 | CYTOKINE PRODUCTION SUPPRESSING COMPOSITION CONTAINING D-ALLOSE AS ACTIVE COMPONENT, AND METHOD OF TREATING OR PREVENTING DISEASE ASSOCIATED WITH CYTOKINE OVERPRODUCTION USING SAME | Non-Final OA | SETOLAS HOLDINGS, INC. |
| 18560456 | APPLICATION OF ALGINATE OLIGOSACCHARIDES | Non-Final OA | HAITANG (JIANGSU) BIOTECHNOLOGY COMPANY, LTD. |
| 17998030 | Tricyclic heterocycles | Final Rejection | Cancer Research Technology Ltd. |
| 18023359 | DRUG-LOADED MACROMOLECULE AND PREPARATION METHOD THEREFOR | Non-Final OA | JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. |
| 18288402 | SOLID FORM OF 2-CHLORO-2'-DEOXY-ADENOSINE COMPLEX WITH HPßCD | Non-Final OA | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. |
| 18552139 | COMPOSITIONS COMPRISING TOPIRAMATE FOR TREATING DERMATOLOGICAL CONDITIONS | Non-Final OA | Sabina GLOZMAN |
| 18550853 | Prevention and Treatment of Periodontal and Peri-Implant Disease | Non-Final OA | LABRIDA AS |
| 18255703 | HUMAN MILK OLIGOSACCHARIDES FOR USE IN SUPPORTING MATURATION OR IMPROVEMENT OF SLEEPING PATTERNS | Non-Final OA | GLYCOM A/S |
| 18006479 | AMINOACIDS FOR TREATMENT OF NEUROLOGICAL DISORDERS | Non-Final OA | ScandiBio Therapeutics AB |
| 17633693 | COMPOUNDS AND COMPOSITIONS FOR DIFFERENTIAL MODULATION OF NICOTINAMIDE ADENINE DINUCLEOTIDE | Non-Final OA | Metro International Biotech, LLC |
| 18000200 | NUCLEIC ACID EXTRACTION METHOD AND APPLICATION | Non-Final OA | NUHIGH BIOTECHNOLOGIES CO., LTD. |
| 17785711 | CROSS-LYNKED HYALURONIC ACID SYNTHESIS PROCESS | Non-Final OA | ISTITUTO GANASSINI S.P.A. DI RICERCHE BIOCHIMICHE |
| 17832165 | Methods of Use of Glucosamine for Increasing Nitrogen Retention | Final Rejection | TSI Bioproducts (Xuzhou) Co., Ltd. |
| 17769522 | CYCLODEXTRIN-BASED GAMMALINOLENIC ACID FORMULATION FOR TREATMENT OF BRAIN CANCER | Non-Final OA | SEFACOR INC. |
| 17624625 | TRANS-CYCLOOCTENE BIOORTHOGONAL AGENTS AND USES IN CANCER AND IMMUNOTHERAPY | Non-Final OA | Tambo, Inc. |
| 17623554 | INHALABLE COMPOSITION COMPROMISING CYCLODEXTRIN FOR USE IN THE TREATMENT OF NASAL INFLAMMATIONS | Non-Final OA | AQUILON PHARMACEUTICALS SA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy